264 related articles for article (PubMed ID: 31010953)
1. Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England.
Mitchell HD; Desai S; Mohammed H; Ong KJ; Furegato M; Hall V; Desai M; Saunders JM; Hughes G; Field N; Gill ON
Sex Transm Infect; 2019 Nov; 95(7):484-487. PubMed ID: 31010953
[TBL] [Abstract][Full Text] [Related]
2. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study.
Hanum N; Cambiano V; Sewell J; Phillips AN; Rodger AJ; Speakman A; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Lampe FC;
Lancet Public Health; 2020 Sep; 5(9):e501-e511. PubMed ID: 32888443
[TBL] [Abstract][Full Text] [Related]
3. An analysis of baseline data from the PROUD study: an open-label randomised trial of pre-exposure prophylaxis.
Dolling DI; Desai M; McOwan A; Gilson R; Clarke A; Fisher M; Schembri G; Sullivan AK; Mackie N; Reeves I; Portman M; Saunders J; Fox J; Bayley J; Brady M; Bowman C; Lacey CJ; Taylor S; White D; Antonucci S; Gafos M; McCormack S; Gill ON; Dunn DT; Nardone A;
Trials; 2016 Mar; 17():163. PubMed ID: 27013513
[TBL] [Abstract][Full Text] [Related]
4. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
[TBL] [Abstract][Full Text] [Related]
5. Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial.
White E; Dunn DT; Desai M; Gafos M; Kirwan P; Sullivan AK; Clarke A; McCormack S;
Sex Transm Infect; 2019 Sep; 95(6):449-454. PubMed ID: 30918121
[TBL] [Abstract][Full Text] [Related]
6. HIV pre-exposure prophylaxis and its implementation in the PrEP Impact Trial in England: a pragmatic health technology assessment.
Sullivan AK; Saunders J; Desai M; Cartier A; Mitchell HD; Jaffer S; Ogaz D; Chiavenna C; Charlett A; Diamente V; Golombek R; Manavi K; Priestley C; Waters LJ; Milinkovic A; McOwan A; Estcourt C; Sabin CA; Rodger A; Gold D; Gazzard BG; McCormack S; Gill ON;
Lancet HIV; 2023 Dec; 10(12):e790-e806. PubMed ID: 38040478
[TBL] [Abstract][Full Text] [Related]
7. Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model.
Kasaie P; Berry SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; Pennington J; German D; Flynn CP; Beyrer C; Dowdy DW
Sex Transm Dis; 2018 Dec; 45(12):791-797. PubMed ID: 29944642
[TBL] [Abstract][Full Text] [Related]
8. Estimating the size of HIV-negative MSM population that would benefit from pre-exposure prophylaxis in Florida.
Mauck DE; Fennie KP; Ibañez GE; Fenkl EA; Sheehan DM; Maddox LM; Spencer EC; Trepka MJ
Ann Epidemiol; 2020 Apr; 44():52-56. PubMed ID: 32145998
[TBL] [Abstract][Full Text] [Related]
9. HIV incidence in an open national cohort of men who have sex with men attending sexually transmitted infection clinics in England.
Desai S; Nardone A; Hughes G; Delpech V; Burns F; Hart G; Gill ON
HIV Med; 2017 Oct; 18(9):615-622. PubMed ID: 28127837
[TBL] [Abstract][Full Text] [Related]
10. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study.
Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW
BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248
[TBL] [Abstract][Full Text] [Related]
11. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
[TBL] [Abstract][Full Text] [Related]
12. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
[TBL] [Abstract][Full Text] [Related]
13. The estimated number of potential PrEP users among gay-identifying men who have sex with men in Australia.
Zablotska IB; Gray R; Whittaker B; Holt M; Wright E; Prestage G; O'Donnell D; Grulich AE
PLoS One; 2018; 13(10):e0204138. PubMed ID: 30335758
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation.
Cambiano V; Miners A; Dunn D; McCormack S; Ong KJ; Gill ON; Nardone A; Desai M; Field N; Hart G; Delpech V; Cairns G; Rodger A; Phillips AN
Lancet Infect Dis; 2018 Jan; 18(1):85-94. PubMed ID: 29054789
[TBL] [Abstract][Full Text] [Related]
15. Population-level effectiveness of pre-exposure prophylaxis for HIV prevention among men who have sex with men in Montréal (Canada): a modelling study of surveillance and survey data.
Doyle CM; Milwid RM; Cox J; Xia Y; Lambert G; Tremblay C; Otis J; Boily MC; Baril JG; Thomas R; Blais AD; Trottier B; Grace D; Moore DM; Mishra S; Maheu-Giroux M
J Int AIDS Soc; 2023 Dec; 26(12):e26194. PubMed ID: 38054579
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of HIV pre-exposure prophylaxis among men-who-have-sex-with-men in England in 2016.
Ong KJ; Desai S; Field N; Desai M; Nardone A; van Hoek AJ; Gill ON
Euro Surveill; 2017 Oct; 22(42):. PubMed ID: 29067902
[TBL] [Abstract][Full Text] [Related]
17. High HIV incidence in men who have sex with men following an early syphilis diagnosis: is there room for pre-exposure prophylaxis as a prevention strategy?
Girometti N; Gutierrez A; Nwokolo N; McOwan A; Whitlock G
Sex Transm Infect; 2017 Aug; 93(5):320-322. PubMed ID: 28729516
[TBL] [Abstract][Full Text] [Related]
18. Real-world trends in incidence of bacterial sexually transmissible infections among gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Australia following nationwide PrEP implementation: an analysis of sentinel surveillance data.
Traeger MW; Guy R; Asselin J; Patel P; Carter A; Wright EJ; Grulich A; McManus H; Fairley CK; Chow EPF; McNulty A; Finlayson R; Bell C; Owen L; Marshall L; Russell D; O'Donnell D; Donovan B; Hellard ME; Stoové MA;
Lancet Infect Dis; 2022 Aug; 22(8):1231-1241. PubMed ID: 35643090
[TBL] [Abstract][Full Text] [Related]
19. High HIV risk and syndemic burden regardless of referral source among MSM screening for a PrEP demonstration project in Toronto, Canada.
Wilton J; Noor SW; Schnubb A; Lawless J; Hart TA; Grennan T; Fowler S; Maxwell J; Tan DHS
BMC Public Health; 2018 Feb; 18(1):292. PubMed ID: 29486737
[TBL] [Abstract][Full Text] [Related]
20. Trends in HIV incidence between 2013-2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study.
Hanum N; Cambiano V; Sewell J; Rodger AJ; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Delpech V; Croxford S; Phillips AN; Lampe FC;
PLoS Med; 2021 Jun; 18(6):e1003677. PubMed ID: 34143781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
